Intensified treatment of type 2 diabetes - Positive effects on blood pressure, but not glycaemic control

QJM - Monthly Journal of the Association of Physicians

Volumn 96, Issue 11, 2003, Pages 833-836

  Gill, G V ^a   Woodward, A ^a   Pradhan, S ^a   Wallymahmed, M ^a   Groves, T ^a   English, P ^a   Wilding, J P ^a  

^a UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET THERAPY; EVIDENCE BASED MEDICINE; FEMALE; HEALTH SURVEY; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MEDICAL EXAMINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PUBLICATION; SYSTOLIC BLOOD PRESSURE;

EID: 0242468136     PISSN: 14602725     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/hcg143     Document Type: Article

References (11)

1. Harris MI. Health care and health status and outcomes for patients with type 2 diabetes. Diabetes Care 2000; 23:754-8.
2. Panzram G. Mortality and survival in type 2 diabetes mellitus. Diabetologia 1987; 30:123-31.
3. Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension and cardiovascular disease: an update. Hypertension 2001; 37:1053-9.
4. United Kingdom Prospective Diabetes Study Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352:837-53.
5. United Kingdom Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). Br Med J 1998; 317:703-13.
6. European Diabetes Policy Group. A desktop guide to type 2 diabetes mellitus. Diabet Med 1999; 16:716-73.
7. Berlowitz DR, Glickman M, Ash AS, Friedman R, Hickey EC, Kader B. Hypertension management in patients with diabetes. Diabetes Care 2003; 26:355-9.
8. Woodward A, Groves T, Wallymahamed M, Wilding JP, Gill GV. Attaining UKPDS management targets in type 2 diabetes: failures and difficulties. Practical Diabetes Int 2001; 18:307-10.
9. The Diabetes Control and Complications Trial (DCCT) Research Group. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin dependent diabetes mellitus. N Engl J Med 1993; 329:977-86.
10. United Kingdom Prospective Diabetes Study Group. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35). Br Med J 2000; 321:405-12.
11. Gaede P, Vedel P, Larsen N, Jensen GVH, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348:383-93.